Finch Therapeutics Raises $53 Million to Advance Microbiome-Based Therapies for Recurrent C. Difficile, Autism and other Disease Areas

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2HmsUqI
via IFTTT